Regeneron Pharmaceuticals (REGN.VI) Q2 2017 Earnings

4MayConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
2.39
2.56
2.73
2.91

Details

Expected EPS
2.8129815
Actual EPS
2.658222
Surprise EPS
-0.15
Surprise Percent
+5.5%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 2.658222 per share for Q2 2017.

0 Comments

Share your thoughts